Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03033160
What this trial is testing

Vaginal Estrogen for Asymptomatic Microscopic Hematuria

Who this might be right for
Asymptomatic Microscopic Hematuria
Boston Urogynecology Associates 68
Testing effectiveness (Phase 2)Study completedNCT01556191
What this trial is testing

Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

Who this might be right for
Stage IV Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 379
Early research (Phase 1)Study completedNCT05551897
What this trial is testing

Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

Who this might be right for
Healthy Subjects
AstraZeneca 14
Testing effectiveness (Phase 2)Study completedNCT01194440
What this trial is testing

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Who this might be right for
Ductal Carcinoma in SituEstrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Early research (Phase 1)Study completedNCT03544125
What this trial is testing

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor NegativeHER2/Neu Negative+3 more
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT02779855
What this trial is testing

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaInvasive Breast Carcinoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 50
Not applicableLooking for participantsNCT06867484
What this trial is testing

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Who this might be right for
Breast CancerCancerCancer of the Breast+3 more
Youssef Zeidan 114
Post-approval studies (Phase 4)Not Yet RecruitingNCT06808347
What this trial is testing

Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women

Who this might be right for
Postmenopausal Atrophic VaginitisGenitourinary Syndrome of Menopause
Walter Reed National Military Medical Center 110
Testing effectiveness (Phase 2)Study completedNCT00733408
What this trial is testing

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+3 more
University of Washington 59
Not applicableStudy completedNCT00283608
What this trial is testing

Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 1,000
Not applicableStudy completedNCT02752893
What this trial is testing

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 10
Large-scale testing (Phase 3)Study completedNCT00391417
What this trial is testing

Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms

Who this might be right for
Hot Flashes
BioSante Pharmaceuticals 431
Not applicableUnknownNCT00133783
What this trial is testing

Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure

Who this might be right for
MenopauseHypertension
Chang Gung Memorial Hospital 500
Not applicableStudy completedNCT01694225
What this trial is testing

Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Who this might be right for
Breast Cancer
University of Louisville 87
Testing effectiveness (Phase 2)Study completedNCT00077025
What this trial is testing

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 174
Not applicableWithdrawnNCT04280523
What this trial is testing

TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University Medical Center
Early research (Phase 1)Active Not RecruitingNCT05509790
What this trial is testing

LY3484356 in Chinese Participants With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 17
Not applicableTemporarily pausedNCT02993068
What this trial is testing

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Who this might be right for
BARD1 Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+12 more
M.D. Anderson Cancer Center 5,200
Not applicableWithdrawnNCT04606550
What this trial is testing

MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study

Who this might be right for
Breast Cancer FemaleGenitourinary Syndrome of Menopause
Mount Sinai Hospital, Canada
Next Page